Jacquelyn L Meyers1, Jian Zhang2, Niklas Manz3, Madhavi Rangaswamy4, Chella Kamarajan2, Leah Wetherill5, David B Chorlian2, Sun J Kang6, Lance Bauer7, Victor Hesselbrock7, John Kramer8, Samuel Kuperman8, John I Nurnberger5, Jay Tischfield9, Jen Chyong Wang10, Howard J Edenberg11, Alison Goate10, Tatiana Foroud5, Bernice Porjesz2. 1. Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, NY, USA. Electronic address: meyersjl@hbnl.downstate.edu. 2. Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, NY, USA. 3. Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, NY, USA; Department of Physics, College of Wooster, Wooster, OH, USA. 4. Department of Psychology, Christ University, Bangalore, India. 5. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. 6. Albany Stratton VA Medical Center, Albany, NY, USA. 7. University of Connecticut School of Medicine, Farmington, CT, USA. 8. Department of Psychiatry, University of Iowa, Iowa City, IA, USA. 9. Rutgers University, Piscataway, NJ, USA. 10. Icahn School of Medicine at Mt. Sinai, New York, NY, USA. 11. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Abstract
BACKGROUND: Differences in fast beta (20-28Hz) electroencephalogram (EEG) oscillatory activity distinguish some individuals with psychiatric and substance use disorders, suggesting that it may be a useful endophenotype for studying the genetics of disorders characterized by neural hyper-excitability. Despite the high heritability estimates provided by twin and family studies, there have been relatively few genetic studies of beta EEG, and to date only one genetic association finding has replicated (i.e., GABRA2). METHOD: In a sample of 1564 individuals from 117 families of European Ancestry (EA) drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), we performed a Genome-Wide Association Study (GWAS) on resting-state fronto-central fast beta EEG power, adjusting regression models for family relatedness, age, sex, and ancestry. To further characterize genetic findings, we examined the functional and behavioral significance of GWAS findings. RESULTS: Three intronic variants located within DSE (dermatan sulfate epimerase) on 6q22 were associated with fast beta EEG at a genome wide significant level (p<5×10-8). The most significant SNP was rs2252790 (p<2.6×10-8; MAF=0.36; β=0.135). rs2252790 is an eQTL for ROS1 expressed most robustly in the temporal cortex (p=1.2×10-6) and for DSE/TSPYL4 expressed most robustly in the hippocampus (p=7.3×10-4; β=0.29). Previous studies have indicated that DSE is involved in a network of genes integral to membrane organization; gene-based tests indicated that several variants within this network (i.e., DSE, ZEB2, RND3, MCTP1, and CTBP2) were also associated with beta EEG (empirical p<0.05), and of these genes, ZEB2 and CTBP2 were associated with DSM-V Alcohol Use Disorder (AUD; empirical p<0.05).' DISCUSSION: In this sample of EA families enriched for AUDs, fast beta EEG is associated with variants within DSE on 6q22; the most significant SNP influences the mRNA expression of DSE and ROS1 in hippocampus and temporal cortex, brain regions important for beta EEG activity. Gene-based tests suggest evidence of association with related genes, ZEB2, RND3, MCTP1, CTBP2, and beta EEG. Converging data from GWAS, gene expression, and gene-networks presented in this study provide support for the role of genetic variants within DSE and related genes in neural hyperexcitability, and has highlighted two potential candidate genes for AUD and/or related neurological conditions: ZEB2 and CTBP2. However, results must be replicated in large, independent samples.
BACKGROUND: Differences in fast beta (20-28Hz) electroencephalogram (EEG) oscillatory activity distinguish some individuals with psychiatric and substance use disorders, suggesting that it may be a useful endophenotype for studying the genetics of disorders characterized by neural hyper-excitability. Despite the high heritability estimates provided by twin and family studies, there have been relatively few genetic studies of beta EEG, and to date only one genetic association finding has replicated (i.e., GABRA2). METHOD: In a sample of 1564 individuals from 117 families of European Ancestry (EA) drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), we performed a Genome-Wide Association Study (GWAS) on resting-state fronto-central fast beta EEG power, adjusting regression models for family relatedness, age, sex, and ancestry. To further characterize genetic findings, we examined the functional and behavioral significance of GWAS findings. RESULTS: Three intronic variants located within DSE (dermatan sulfate epimerase) on 6q22 were associated with fast beta EEG at a genome wide significant level (p<5×10-8). The most significant SNP was rs2252790 (p<2.6×10-8; MAF=0.36; β=0.135). rs2252790 is an eQTL for ROS1 expressed most robustly in the temporal cortex (p=1.2×10-6) and for DSE/TSPYL4 expressed most robustly in the hippocampus (p=7.3×10-4; β=0.29). Previous studies have indicated that DSE is involved in a network of genes integral to membrane organization; gene-based tests indicated that several variants within this network (i.e., DSE, ZEB2, RND3, MCTP1, and CTBP2) were also associated with beta EEG (empirical p<0.05), and of these genes, ZEB2 and CTBP2 were associated with DSM-V Alcohol Use Disorder (AUD; empirical p<0.05).' DISCUSSION: In this sample of EA families enriched for AUDs, fast beta EEG is associated with variants within DSE on 6q22; the most significant SNP influences the mRNA expression of DSE and ROS1 in hippocampus and temporal cortex, brain regions important for beta EEG activity. Gene-based tests suggest evidence of association with related genes, ZEB2, RND3, MCTP1, CTBP2, and beta EEG. Converging data from GWAS, gene expression, and gene-networks presented in this study provide support for the role of genetic variants within DSE and related genes in neural hyperexcitability, and has highlighted two potential candidate genes for AUD and/or related neurological conditions: ZEB2 and CTBP2. However, results must be replicated in large, independent samples.
Authors: Madhavi Rangaswamy; Bernice Porjesz; David B Chorlian; Kongming Wang; Kevin A Jones; Lance O Bauer; John Rohrbaugh; Sean J O'Connor; Samuel Kuperman; Theodore Reich; Henri Begleiter Journal: Biol Psychiatry Date: 2002-10-15 Impact factor: 13.382
Authors: Chupong Ittiwut; Bao-Zhu Yang; Henry R Kranzler; Raymond F Anton; Rungnapa Hirunsatit; Roger D Weiss; Jonathan Covault; Lindsay A Farrer; Joel Gelernter Journal: Alcohol Clin Exp Res Date: 2011-09-15 Impact factor: 3.455
Authors: G J Lydall; J Saini; K Ruparelia; S Montagnese; A McQuillin; I Guerrini; H Rao; G Reynolds; D Ball; I Smith; A D Thomson; M Y Morgan; H M D Gurling Journal: Neurosci Lett Date: 2011-06-12 Impact factor: 3.046
Authors: Stephen M Malone; Scott J Burwell; Uma Vaidyanathan; Michael B Miller; Matt McGue; William G Iacono Journal: Psychophysiology Date: 2014-12 Impact factor: 4.016
Authors: Bernice Porjesz; Laura Almasy; Howard J Edenberg; Kongming Wang; David B Chorlian; Tatiana Foroud; Alison Goate; John P Rice; Sean J O'Connor; John Rohrbaugh; Samuel Kuperman; Lance O Bauer; Raymond R Crowe; Marc A Schuckit; Victor Hesselbrock; P Michael Conneally; Jay A Tischfield; Ting-Kai Li; Theodore Reich; Henri Begleiter Journal: Proc Natl Acad Sci U S A Date: 2002-03-12 Impact factor: 11.205
Authors: Dirk J A Smit; Margaret J Wright; Jacquelyn L Meyers; Nicholas G Martin; Yvonne Y W Ho; Stephen M Malone; Jian Zhang; Scott J Burwell; David B Chorlian; Eco J C de Geus; Damiaan Denys; Narelle K Hansell; Jouke-Jan Hottenga; Matt McGue; Catharina E M van Beijsterveldt; Neda Jahanshad; Paul M Thompson; Christopher D Whelan; Sarah E Medland; Bernice Porjesz; William G Lacono; Dorret I Boomsma Journal: Hum Brain Mapp Date: 2018-06-26 Impact factor: 5.038
Authors: Clarissa C Parker; Vivek M Philip; Daniel M Gatti; Steven Kasparek; Andrew M Kreuzman; Lauren Kuffler; Benjamin Mansky; Sophie Masneuf; Kayvon Sharif; Erica Sluys; Dominik Taterra; Walter M Taylor; Mary Thomas; Oksana Polesskaya; Abraham A Palmer; Andrew Holmes; Elissa J Chesler Journal: Alcohol Clin Exp Res Date: 2022-04-17 Impact factor: 3.928
Authors: Dirk J A Smit; Ole A Andreassen; Dorret I Boomsma; Scott J Burwell; David B Chorlian; Eco J C de Geus; Torbjørn Elvsåshagen; Reyna L Gordon; Jeremy Harper; Ulrich Hegerl; Tilman Hensch; William G Iacono; Philippe Jawinski; Erik G Jönsson; Jurjen J Luykx; Cyrille L Magne; Stephen M Malone; Sarah E Medland; Jacquelyn L Meyers; Torgeir Moberget; Bernice Porjesz; Christian Sander; Sanjay M Sisodiya; Paul M Thompson; Catharina E M van Beijsterveldt; Edwin van Dellen; Marc Via; Margaret J Wright Journal: Brain Behav Date: 2021-07-21 Impact factor: 2.708